Among the regenerative therapies available today, EBO2 has earned a reputation as one of the most comprehensive blood wellness protocols. Here is why so many patients at our Rancho Palos Verdes clinic make it a regular part of their plan.
A comprehensive protocol
EBO2 layers filtration, oxygenation, and UV light in a single, physician-supervised session. That layered approach is one of the reasons it stands out among single-modality therapies.
Patient experience
Patients consistently describe EBO2 as a calm, controlled experience. The clinical team is present from intake through recovery, and the private treatment setting makes the visit feel restorative rather than clinical.
Where EBO2 fits in a broader plan
EBO2 is often paired with IV therapy, EBO3 therapy, peptides, or anti-aging protocols. Our team will help you map a plan that combines the right therapies in the right cadence.
If you have been comparing blood wellness options, the best next step is a complimentary consultation with our team. We are based in Rancho Palos Verdes and serve patients across Palos Verdes, Torrance, Harbor City, and San Pedro.
Ready to talk with our team?
Book a complimentary consultation at our Rancho Palos Verdes clinic.
Request a ConsultationRelated services
Related reading
More from the EBO2 Therapy and Wellness library.
EBO3 Therapy vs. 10-Pass Ozone Therapy: A Side-by-Side Comparison
How EBO3 compares to traditional 10-pass ozone protocols — including continuous filtration, oxygenation capacity, and what each is best suited for.
Read
How EBO3 Therapy Supports Cellular Rejuvenation
An overview of EBO3 and the cellular wellness pathways it is designed to support, written for patients in Rancho Palos Verdes and the South Bay.
ReadEverything You Need to Know About EBO2 Treatment
What EBO2 treatment is, what a session actually looks like, and how to know whether the protocol belongs in your longer-term wellness plan today.
ReadEBO3 is a clinic-branded wellness protocol. These references describe ozone's regulatory context and the state of the published evidence; they do not establish EBO3 as a treatment for any disease, and ozone therapy is not FDA-approved. Published EBOO/ozone literature is heterogeneous, largely preliminary or uncontrolled, and mostly of low or very-low certainty.
- 21 CFR § 801.415 — Federal regulation on ozone (labeling context)
eCFR (U.S. Electronic Code of Federal Regulations)
Federal labeling regulation for medical devices generating ozone. Regulatory context only; does not indicate FDA approval of ozone as a therapy.
- Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful
Mediators of Inflammation (PMID 16156950)
Narrative review discussing extracorporeal blood oxygenation with ozone (EBOO) and related ozone modalities. Evidence at the time was preliminary and largely uncontrolled — insufficient to validate EBOO for any disease indication.
- Umbrella review of ozone therapy across clinical indications
Medical Sciences (DOI 10.3390/medsci14020289)
Umbrella review of systematic reviews of ozone therapy across multiple indications. Findings are heterogeneous with most conclusions rated low or very-low certainty; overall evidence remains insufficient to establish general clinical efficacy.
- Smith NL et al. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility
Medical Gas Research (PMID 29152215)
Peer-reviewed overview of ozone therapy noting that the current clinical evidence base is heterogeneous and further rigorous study is needed.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.
Medical Disclaimer: Information on this website is for educational purposes only and is not a substitute for medical advice. Individual results vary. Consult a qualified healthcare provider before beginning any treatment.